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Fat Facets Interacts with Vasa in the Drosophila
Pole Plasm and Protects It from Degradation
trol were excised from a similar reverse-stained gel, and
the proteins contained therein were identified by mass
spectrometry. This major complex contained essentially
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Montreal, Quebec, H3A 1B1 only FAF (45 sequences) and VAS (18 sequences). Three
unknown sequences and rabbit IgG (12 sequences,Canada
likely resulting from residual rabbit anti-VAS from the
immunoprecipitation) were also recovered. Analysis of
BMH-crosslinked ovarian VAS-containing extracts alsoSummary
indicated the presence of FAF (data not shown). We
therefore conclude that FAF physically associates withAnterior-posterior patterning and germ cell specifica-
VAS in vivo.tion in Drosophila requires the establishment, during
oogenesis, of a specialized cytoplasmic region termed
the pole plasm [1, 2]. Numerous RNAs and proteins Embryos from faf Mothers Not Only Form
accumulate to the pole plasm and assemble in polar Fewer Pole Cells, but Also Exhibit Defects
granules. Translation of some of these RNAs is gener- in Nuclear Divisions
ally repressed and active only in pole plasm [1, 2]. Vasa FAF is a deubiquitinating enzyme (DUB) essential mater-
(VAS) protein, an RNA helicase and a component of nally for normal development of the embryo and zygoti-
polar granules, is essential maternally for posterior cally for development of the compound eye [7, 9, 10].
patterning and germ cell specification, and VAS is a Because FAF is localized to the pole plasm [7], we as-
candidate translational activator in the pole plasm sessed the functionality of the pole plasm in embryos
[3, 4]. VAS is stabilized within the pole plasm in that collected from fafB3 females by counting the numbers
it is initially present throughout the entire embryo but of germ cells that formed, using anti-VAS as a marker.
strictly limited to the pole cells by the cellular blasto- We found that 78% of the embryos produced by fafB3
derm stage [5]. hsp83 mRNA, which accumulates in females had no pole cells and no localized VAS staining.
the pole plasm through a stabilization-degradation Only 7% of the embryos formed pole cells, and in all
mechanism [6], is another example. Here, we used a cases there were far fewer such cells than in wild-type
biochemical approach to identify proteins that copur- embryos. The pole cells that formed in the progeny em-
ify with VAS in crosslinked extracts. Prominent among bryos of faf females also showed a variety of migration
these proteins was the ubiquitin-specific protease Fat defects (Figure 2A). The remaining 15% of embryos
facets (FAF), a pole plasm component [7], but one showed localized VAS staining but formed no pole cells.
whose roles in posterior patterning and germ line Loss of maternal faf function also affected somatic de-
specification have remained unclear. We present evi- velopment; most notably, many progeny embryos of
dence that FAF interacts with VAS physically and re- faf females failed to undergo or had aberrant nuclear
verses VAS ubiquitination, thereby stabilizing VAS in divisions. Nuclear staining revealed that 45% of the eggs
the pole plasm. produced by faf females are unfertilized (one nucleus),
12% arrested at a two nuclear stage, and 40% are multi-
nucleated, but the arrangement of their nuclei was usu-Results and Discussion
ally irregular (Figure 2B). These failures in nuclear divi-
sion must also contribute to the defects in pole cellCrosslinking and Purification
formation and migration that we observed.of the VAS-FAF Complex
As a complementary approach to yeast two-hybrid
screening to identify Vasa (VAS)-interacting proteins The Amount of VAS Protein in the Pole Plasm
[4, 8], we biochemically isolated VAS-containing com- Is Dependent on faf
plexes by a novel crosslinking and tandem immunopre- To test whether faf activity is related to VAS stability,
cipitation approach (see Supplemental Data) using the we first immunostained wild-type and fafB3 mutant ova-
crosslinking agent BMH (N,N’-bis [3-maleinido-propio- ries and embryos to observe VAS localization and levels
nyl]-2-hydroxy-1,3-propanediamine). With increasing in situ. During normal oogenesis, VAS collects in punctate
BMH concentrations, high molecular weight VAS com- perinuclear RNP (ribonucleoprotein) structures called nu-
plexes formed while the level of free VAS decreased age and is abundant in the cytoplasm of nurse cells
(Figures 1A and 1B). These complexes were further puri- through stage 10. It then accumulates in the pole plasm.
fied by continuous elution electrophoresis. Fractions In fafB3 mutant ovaries, the level and distribution of VAS
collected from this procedure were subject to a second in nurse cells appeared normal, but the intensity of VAS
immunoprecipitation, and the recovered protein was re- immunoreactivity in the pole plasm was consistently
solved by SDS-PAGE (SDS-polyacrylamide gel electro- reduced relative to wild-type (Figures 3A and 3B). We
phoresis) and visualized with silver staining (Figure 1C). also observed a substantial reduction in OSK accumula-
Bands corresponding to the VAS complex and the con- tion in fafB3 mutant ovaries (Figure 3C), but no significant
change in posterior Tudor (TUD) or Staufen (STAU) levels
(Figures 3D and 3E). Similarly, a reduction in posteriorly*Correspondence: paul.lasko@mcgill.ca
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Figure 1. Western Blot Patterns of Crosslinked Embryo Extract Labeled with Anti-VAS Antiserum
(A) 6% SDS-PAGE. Lanes 1–7, increasing BMH concentration: 1, 5, 10, 25, 50, 100, 500 g/mL; lane 8, no BMH. Arrows indicate two different
VAS complexes, and the arrowhead indicates free VAS. The complex indicated by the lower arrow contains VAS (13 sequences) and the p135
subunit of eukaryotic translation initiation factor 3 (CG8443, one sequence).
(B) 3.4% SDS-PAGE strengthened with 1% agarose. Lane 1, no BMH; lane 2, 25 g/mL of BMH as in (A), lane 4. Arrowhead indicates the
VAS complex that was purified and analyzed in this work. Arrows indicate other VAS complexes. Molecular mass markers are indicated to
the left.
(C) The resolved VAS complex after the second immunoprecipitation (IP) (7.5% SDS-PAGE, silver-stained). Lane 1, sample of second control
IP with preimmune serum; lane 2, sample of second anti-VAS IP; lane 3, supernatant from second anti-VAS IP. Arrow C indicates the position
of the purified VAS complex corresponding to the VAS complex in (B) (arrowhead). Brackets indicate the portions of the gel that were excised
and microsequenced. The VAS complex indicated by arrow C contained FAF (45 sequences), VAS (18 sequences), three unknown sequences,
and rabbit IgG (12 sequences). The gel slices sent for sequencing were excised from a 7.5% SDS-PAGE visualized by imidazole-zinc salt
reverse staining. The 7.5% SDS gel was used to prevent diffusion of the purified VAS complex in a low concentration gel.
localized VAS was observed in cleavage embryos col- (Figure 4B), indicating that the reduced stability of VAS
in fafB3 is not a general characteristic of all pole plasmlected from fafB3 mutant females, but the intensity of
NOS immunoreactivity in these embryos was relatively proteins or a nonspecific consequence of the fafB3 em-
bryonic lethal phenotype in which development oftenunaffected (Figures 3F and 3G).
To confirm the decrease in VAS levels observed by arrests after zero or one nuclear divisions (Figure 2B).
Taken together, these experiments indicate that FAF isimmunostaining, we compared VAS levels in ovary and
embryo by Western analysis of extracts prepared from required for the normal stabilization of VAS.
wild-type and fafB3 homozygotes. VAS was decreased
by 49% in fafB3 mutant ovaries, as compared to wild- VAS Is Ubiquitinated In Vivo and Deubiquitinated
by FAFtype, and by 88% in 1–2 hr fafB3 embryos (Figures 4A
and 4B). We did not observe any reduction in a control If FAF prevents proteolysis of VAS protein by deubiquiti-
nating it, then more ubiquitinated VAS would be presentprotein, Bicaudal-D (BIC-D), or in the polar granule com-
ponent TUD in fafB3 mutant ovaries (Figure 4A). We also in faf mutant ovaries than in wild-type ovaries. To exam-
ine the ubiquitination state of VAS, we concentratedobserved no effect of the fafB3 mutation on levels of
Exuperantia (EXU), ME31B, or Bicaudal-C (BIC-C) (data VAS by immunoprecipitation from wild-type and fafB3
mutant ovary extracts and then detected VAS and ubi-not shown). Additionally, we did not observe any reduc-
tion in Hsp83 protein levels in fafB3 mutant embryos quitin (Ub) by Western analysis (Figure 4C). A ladder of
Figure 2. Pole Cell Number, Pole Cell Migra-
tion, and Nuclear Divisions in Early Embryos
Are Affected by Loss of faf
Pole cells were detected in 0–6 hr embryos
from wild-type or fafB3 mutant mothers by
staining with anti-VAS (A). Pole cells that do
form fail to migrate into the abdomen and
instead spread out over the embryo surface
in fafB3 mutant embryos. Staining with the flu-
orescent DNA marker Hoechst 33258 in-
dicates that many eggs produced by fafB3
mutant females arrest with only one or two
nuclei and that embryos that progress be-
yond this point have an abnormal distribution
of nuclei (B).
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higher-molecular-weight forms of VAS was observed in
fafB3 mutant extracts, but these forms of VAS were nearly
undetectable in extracts prepared from wild-type ova-
ries (Figure 4C, -Ub). Several lines of evidence indicate
that this ladder represents ubiquitinated forms of VAS.
First, the samples for Western analysis were prepared
by immunoprecipitating with antibodies specific to VAS,
highly enriching for Ub attached to VAS rather than to
other proteins. Second, the anti-Ub staining becomes
stronger with increasing molecular weight until eventu-
ally fading out. We interpret this to represent attachment
of increasing numbers of Ub residues to a VAS mono-
mer, followed by the degradation of poly-ubiquitinated
VAS. Finally, the incremental size differences between
many of the bands of the ladder are approximately con-
sistent with the size of a Ub monomer (Figure 4C, fafB3).
Additional bands we observe most likely correspond to
other posttranslationally modified forms of VAS [11].
Control immunoprecipitations were performed with
anti-BIC-D from wild-type and fafB3 mutant ovary ex-
tracts. Consistent with our earlier observations that indi-
cated no effect of the maternal fafB3 mutation on BIC-D
levels (Figure 4A), no ladder of ubiquitinated BIC-D is
detected in wild-type or fafB3 mutant ovary extracts (Fig-
ure 4D, -Ub). We also performed Western analysis of
wild-type and fafB3 mutant ovary extracts with anti-VAS.
Ubiquitinated forms of VAS could be detected in extracts
prepared from the fafB3 mutant (Figure 4E) when high
amounts of protein and a long exposure time were used.
Therefore, we conclude that VAS is ubiquitinated during
oogenesis and that ubiquitinated VAS is subsequently
deubiquitinated by FAF, thereby protecting VAS from
proteasome-mediated degradation.
Conclusions
We have shown that VAS and FAF can be copurified from
chemically crosslinked embryonic and ovarian extracts
and that in faf mutants, the ubiquitination of VAS is
increased and its levels are decreased in ovaries and
more strikingly in progeny embryos. The simplest inter-
pretation of these data is that VAS is a specific substrate
for the deubiquinating enzyme FAF. We believe the re-
duction of localized OSK we observe in faf mutant ova-
ries is an indirect result of the reduced stability of VAS,
since vas function is required for the stable accumula-
tion of OSK in the pole plasm [12–14]. The apparent
reduction in TUD levels in Figure 3D is not supported
by quantitative Western analysis (Figure 4A) and is not
consistent among individual stage 10 oocytes.
Figure 3. FAF Affects Early Pole Plasm Formation
Heterozygotes for a vas null mutation produce em-
Accumulation of VAS at the oocyte posterior is consistently reduced bryos with a 20%–25% reduction in pole cell number [4],
in fafB3 mutant egg chambers while perinuclear nurse cell VAS levels
yet such embryos, unlike progeny of faf mutant mothers,are normal (A and B). Posterior OSK levels are also reduced in the
show prominent posterior VAS staining. The severe phe-fafB3 mutant (C), while two other pole plasm components, TUD (D)
and STAU (E), are not affected. Posterior accumulation of VAS is notype of embryos produced by homozygous faf moth-
also reduced in fafB3 mutant cleavage-stage embryos (F), while the ers (Figure 2) renders difficult a direct analysis of its
level of posterior NOS is essentially unaffected (G). The embryos in requirement in the pole plasm. However, based on the
Figures 3F and 3G are atypical in that only 26% of 0–2 hr embryos vas heterozygous phenotype, the obvious reduction in
from faf mutant mothers show localized VAS staining, and 46%
posterior VAS accumulation in faf mutants should affectshow posterior NOS staining that is not as tightly localized as in
development, and therefore FAF-mediated stabilizationwild-type.
of VAS must contribute to pole plasm function. FAF-
mediated protection of VAS is mostly restricted to the
pole plasm, perhaps because during oogenesis, FAF
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Figure 4. The Amount of VAS Protein Is Af-
fected in the fafB3 Mutant
(A) Western blot of wild-type and fafB3 mutant
ovary extracts. Lanes 1 and 2 are labeled with
anti-VAS and anti--tubulin, lanes 3 and 4
with anti-BIC-D and anti--tubulin, and lanes
5 and 6 with anti-TUD and anti--tubulin. The
amount of VAS protein was decreased by
49% in fafB3 mutant ovaries as compared to
wild-type, while the levels of BIC-D and TUD
were not affected. The numbers below the
images are the ratio of VAS:tubulin, BIC-D:
tubulin, or TUD:tubulin proteins in the various
extracts, as normalized to their ratio in wild-
type (n  6).
(B) Western blot of wild-type and fafB3 mutant
embryo extracts. The amount of VAS protein
was decreased by 88% in fafB3 mutant em-
bryos as compared to wild-type (lanes 1 and
2), while the level of Hsp83 was not affected
(lanes 3 and 4) (n  6).
(C) Western blots of anti-VAS immunoprecipi-
tated samples (IP: -VAS), labeled first with
anti-Ub (Ub), then with anti-VAS reusing
the same membrane. Extracts were from
wild-type (wt) or fafB3 mutant ovaries. The ver-
tical line indicates the range of ubiquitinated
VAS. Poly-ubiquitinated VAS (Ub-VAS) is
present in fafB3 mutant extracts, but not in
wild-type extracts. fafB3 is a strong allele with
Q71 changed to a premature stop codon [23].
(D) Western blots of anti-BIC-D immunoprecipitated samples (IP: -BIC-D), labeled first with anti-Ub then with anti-BIC-D reusing the same
membrane. Extracts are from wild-type or fafB3 mutant ovaries. There is no apparent difference in BIC-D staining between wild-type and the
fafB3 mutant.
(E) Western blot of wild-type and fafB3 ovary extracts labeled with anti-VAS. Using high protein concentrations and a long exposure time, the
ubiquitinated forms of VAS can be seen in the fafB3 mutant.
itself becomes localized to the posterior pole and is bility of -catenin and the Ras target AF-6 [19, 20]. Ge-
netic evidence indicates that the Drosophila homologsincorporated into pole cells [7]. As is the case for other
pole plasm components, FAF localization depends on of Af-6 (canoe) and -catenin (armadillo) do not encode
the essential faf substrate in the eye [15], nor is thereosk function, and a role for FAF in germ cell differentia-
tion and development has previously been proposed any present evidence that suggests that either is a sub-
strate for FAF in the ovary. A biochemical approach[7]. Interestingly, Usp9x, a bona fide mouse ortholog of
FAF, is predominantly expressed in both germ cell and analogous to the one presented here using reagents
to purify FAF-containing complexes could enable thesupporting cell lineages during gonadal development
[15, 16], suggesting a conserved role for FAF in mamma- identification of unknown FAF substrates, and an analy-
sis of FAF and its substrates may provide insight intolian germ line development.
Eukaryotic genomes encode large families of DUBs. the basis of substrate specificity of DUBs.
Although FAF was a known pole plasm component,They can potentially perform regulatory roles, as they
are associated with the control of a wide variety of bio- it was not recovered in our previous yeast two-hybrid
screens using VAS as bait. Similarly, some of the VAS-logical processes including tumor suppression, tran-
scription, cell growth, chromosome condensation, neu- interacting proteins we recovered from the two-hybrid
screens were not recovered in our immunoprecipitationral pathfinding, and memory storage [17, 18]. However,
few examples of specific substrates for specific DUBs experiments. The combination of the crosslinking tech-
nique [21, 22] with tandem immunoprecipitations greatlyhave yet been identified, and very little is known about
how substrate specificity is achieved for these enzymes. reduced nonspecific protein contamination of the VAS-
containing complexes, yet a weakness of the biochemi-Interestingly, another specific substrate is known for
FAF itself, which mediates its function in eye develop- cal approach is that it preferentially favors the recovery
of relatively abundant proteins. Conversely, the two-ment. This substrate is Liquid facets (LQF), an endocytic
protein homologous to vertebrate epsin. FAF reverses hybrid system is essentially independent of the expres-
sion level of the protein in question, but many proteinsthe ubiquitination of LQF, thereby preventing proteaso-
mal degradation of that protein [10]. Our phenotypic are not amenable to this system because of problems
including autoactivation, failure to localize to the appro-analysis of the progeny embryos produced by faf fe-
males indicates that in addition to VAS and LQF, at least priate cellular compartment, and toxicity to yeast. We
suggest that biochemical approaches to identifying in-one more substrate must exist for FAF, with an essential
function in cell cycle regulation and/or nuclear division. teracting proteins, such as the one presented here, yield
complementary information to the two-hybrid systemIn mammals, the FAF ortholog Usp9x regulates the sta-
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deubiquitinating enzyme and FAM, its mouse homolog. Dev.and are a valuable tool to use in assessing in vivo pro-
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